title: Ruptured abdominal aortic aneurysms due to Salmonella, not of typhi species.
abstract: Ruptured aortic aneurysms due to Salmonella not of typhi species are rare and associated with high morbidity and mortality. We present three patients with Salmonella-infected ruptured aortic aneurysms successfully treated with an in situ prosthetic bypass graft. One patient had a saccular aneurysm at the infrarenal aorta and two patients had fusiform aneurysms at the aortic bifurcation. All the patients were treated with wide debridement of the infected aortic tissue followed by in situ graft replacement and long-term systemic antibiotic therapy. The method of revascularization, in situ bypass or extraanatomic bypass, remains controversial. On the basis of our clinical experience and recent literature focusing on more than 10 cases, in situ bypass reconstruction may be a feasible surgical technique for Salmonella-infected ruptured aortic aneurysm.
authors.affiliation: Division of Vascular Surgery, Department of Surgery, University of Ulsan College of Medicine and Asian Medical Center, Seoul, Korea. twkwon2@amc.seoul.kr
authors.forename: Tae-Won
authors.initials: TW
authors.lastname: Kwon
authors.forename: Eui-Sup
authors.initials: ES
authors.lastname: Shin
authors.forename: Do-kyun
authors.initials: DK
authors.lastname: Kim
authors.forename: Sang-Oh
authors.initials: SO
authors.lastname: Lee
authors.forename: Geun-Eun
authors.initials: GE
authors.lastname: Kim
mesh_terms: D000368:Aged; D000785:Aneurysm, Infected / Q000150:complications* / Q000382:microbiology / Q000628:therapy; D017542:Aneurysm, Ruptured / Q000382:microbiology* / Q000628:therapy; D000890:Anti-Infective Agents / Q000627:therapeutic use; D017544:Aortic Aneurysm, Abdominal / Q000382:microbiology* / Q000628:therapy; D001807:Blood Vessel Prosthesis; D002939:Ciprofloxacin / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D011138:Polytetrafluoroethylene; D012480:Salmonella Infections / Q000150:complications* / Q000382:microbiology / Q000628:therapy
chemical_list: D000890:Anti-Infective Agents; D002939:Ciprofloxacin; D011138:Polytetrafluoroethylene